Carbon Ion Radiation Therapy for Locally Advanced Pancreatic Cancer
Status:
Completed
Trial end date:
2019-07-09
Target enrollment:
Participant gender:
Summary
This is a phase I trial to determine the maximum tolerated dose of carbon ion radiotherapy
for the treatment of locally advanced, unresectable, pancreatic cancer.
Phase:
Phase 1
Details
Lead Sponsor:
Albert Einstein College of Medicine Albert Einstein College of Medicine, Inc.